Skip to content
Open access

ASOCompass: Context- and Chemistry-Aware Activity Prediction for Transferable Antisense Oligonucleotide Screening

Aug 2026 · bioRxiv · 0 citations · 38 references
Biology

TL;DR

ASOCompass, a context-and chemistry-aware framework for ASO activity prediction and candidate ranking, is introduced and the potential of jointly modeling sequence, chemistry, and experimental-biological context for transferable ASO screening is demonstrated.

Abstract

Antisense oligonucleotide (ASO) activity is jointly influenced by nucleotide sequence, chemical modification, target-RNA context, dose, delivery protocol, and cellular environment. Most existing computational screening methods model only a subset of these factors, limiting their ability to predict experimentally measured activity across heterogeneous screening conditions and previously unseen biological contexts. We introduce ASOCompass, a context-and chemistry-aware framework for ASO activity prediction and candidate ranking. ASOCompass integrates contextualized ASO and target-RNA sequence representations with position-specific molecular representations of chemical modifications. It further incorporates dose and delivery information together with prototype-adapted transcriptomic representations of target genes and cell lines. To encourage chemically and biophysically informative representations, the model is jointly trained on auxiliary molecular-property and sequence-derived thermodynamic prediction tasks. We evaluate ASOCompass on ASO Atlas, a large patent-derived dataset of RNase H-mediated gapmer ASOs, under held-out drug, target-gene, cell line, and joint gene–cell line settings. ASOCompass achieves an overall Spearman correlation of 0.5970, improving over the strongest ASO-specific baseline by 0.0421, and consistently performs best across all four distribution shifts. When adapted to unseen SOD1 and KLKB1 targets, ASOCompass also provides more accurate candidate ranking across different annotation budgets, reaching correlations of 0.830 and 0.696 with 1,024 target-specific labels. Additional analyses suggest that molecular-property supervision improves modification-specific ranking, while the auxiliary thermodynamic task produces representations more closely aligned with measured inhibition. These results demonstrate the potential of jointly modeling sequence, chemistry, and experimental-biological context for transferable ASO screening.

Read PDF

Similar papers

Open access Sep 2026

ASOFormer: a Transformer-based model for predicting antisense oligonucleotide efficacy to support therapeutic candidate prioritization

A novel Transformer-based neural network that predicts the inhibition efficiency of RNase H-mediated ASOs from sequence, predicted secondary structure, and chemical modification features, ASOFormer achieved the best overall accuracy and prioritized the strongest inhibitors.

N. Dove, Yu-Hao Min, Özkan Iş et al. · 0 citations
Open access Sep 2026

LLM-guided prediction of riboswitch-ligand binding affinity under data-limited conditions.

A neuro-symbolic framework in which LLM-derived embeddings encode riboswitch sequences, secondary structures, and ligand representations into a unified representation that captures riboswitch-ligand interaction context, while domain-informed rules encode explicit biochemical priors is presented.

Sunggi An, Sofia Mun, Yousung Jung et al. · 0 citations
Open access Sep 2026

AET5: A transcriptome-guided molecular generation framework with contrastive self-supervised learning

AET5 is presented, a de novo molecular generation framework that conditions molecular design on disease-reversal gene expression profiles, providing a general framework for biologically informed drug design under noisy transcriptomic conditions.

Zhi-Kang Yuan, Xin Zhang, Gao-Ming Lin et al. · 0 citations
Open access Sep 2026

HARIBOSS++: An Integrated Platform for RNA-Targeted Drug Design

HARIBOSS++ is presented, an updated and next-generation platform designed to facilitate the study of future RNA-targeted drugs and opens new avenues for biologists, bioinformaticians, and machine learning researchers to investigate RNA-SM interactions on a new scale.

Matteo Marengo, Elodie Chapeaublanc, Hervé Ménager et al. · 0 citations
Open access Sep 2026

DLRNA-BERTa: a transformer approach for predicting molecule-RNA binding affinities

DLRNA-BERTa is introduced, a RoBERTa-based framework that integrates RNA-BERTa and ChemBERTa-v2 to model molecule–RNA binding affinities and has potential utility for RNA-based drug repurposing and prioritization of candidate molecules for further investigation.

Pasquale Lobascio, Khalid Saeed, Asifullah Khan et al. · 0 citations
#artificial intelligence Preprint Sep 2026

One Sequence, Many Decodings: CAGenMol-2 Recasts Drug Design as Masked Molecular Inference

CAGenMol-2, a masked diffusion molecular language model that represents molecules, continuous scalar properties, and 3D protein pockets within a single wrapped sequence is introduced, allowing one checkpoint to perform property prediction, property- and pocket-conditioned generation, and partial-constraint design witho...

Yan-Ting Li, En-Yang Dai, Lei Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.